Eledon Pharmaceuticals Inc (ELDN NASDAQ) stock market data APIs
$2.4234
-0.06(-2.5%)
as of September 17, 2025
Try our APIs with
free plan!
Eledon Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Prev. Close
2.4234
Open
2.3676
High
2.4828
Low
2.3418
52 wk Range
2.315-5.54
Market Cap
146 M
P/E Ratio
3.7385
Shares Outstanding
59 882 K
EPS
-0.13
Beta
-0.117
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eledon Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eledon Pharmaceuticals Inc data using free add-ons & libraries
Get Eledon Pharmaceuticals Inc Fundamental Data
Eledon Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -36 862 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.22
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eledon Pharmaceuticals Inc News
New
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will partici...
Eledon Posts Narrower Loss in Q2
Key Points Earnings per share (GAAP) was $0.13 for Q2 2025, outperforming GAAP estimates for a loss of $0.23. Net loss (GAAP) fell to $11.2 million for Q2 2025, due to a significant gain from changes...
Eledon Pharmaceuticals GAAP EPS of -$0.13
* Eledon Pharmaceuticals press release [https://seekingalpha.com/pr/20201992-eledon-pharmaceuticals-reports-second-quarter-2025-operating-and-financial-results] (NASDAQ:ELDN [https://seekingalpha.co...
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
Updated data from ongoing open-label Phase 1b trial demonstrated a mean 12-month eGFR of approximately 68 mL/min/1.73 m2 post-transplant for patients on tegoprubart Company on track to report topline...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
